Business Wire1d
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...
Apple Cancels Mac-Connected AR Smart Glasses
Apple is no longer developing augmented reality glasses designed to pair with the Mac, reports Bloomberg's Mark Gurman. Apple ...